Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to learn whether bismuth subsalicylate can reduce use of antibiotics among adults with diarrhea in Pakistan.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Centers for Disease Control and Prevention
• Collaborators: Health Oriented Preventive Education; Procter and Gamble
• Treatments: Anti-Infective Agents; Bismuth; Bismuth subsalicylate

Criteria

Inclusion Criteria:

• Persons aged 15 - 65 years old

• Presenting with mild to moderate, non-bloody, acute diarrhea (≥3 loose stools/day for <3 days) to participating health care settings

• For whom the study physicians recommend antimicrobial treatment

Exclusion Criteria:

• Is pregnant

• Requires hospitalization

• Has signs or symptoms of septicemia

• Has a primary complaint of another acute illness

• Has a serious chronic illness

• Has an allergy to aspirin

• Has been exposed to antimicrobial or antidiarrheal medications within 72 hours of enrollment

• Previously enrolled in study